Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
PubMed (MeSH Keyword) for id: 71297207
3 results
Results by year
Filters applied: . Clear all
Page 1
B-cell lymphoma-extra large is a promising drug target in Merkel cell carcinoma.
Br J Dermatol. 2023 Jul 7;189(1):103-113. doi: 10.1093/bjd/ljad099.
Br J Dermatol. 2023.
PMID: 36991156
Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expression.
Pesch AM, Chandler BC, Michmerhuizen AR, Carter HM, Hirsh NH, Wilder-Romans K, Liu M, Ward T, Ritter CL, Nino CA, Jungles KM, Pierce LJ, Rae JM, Speers CW.
Pesch AM, et al.
Cancer Res Commun. 2022 Jul;2(7):679-693. doi: 10.1158/2767-9764.crc-22-0024. Epub 2022 Jul 20.
Cancer Res Commun. 2022.
PMID: 36381235
Free PMC article.
Item in Clipboard
BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
Chiou JT, Lee YC, Wang LJ, Chang LS.
Chiou JT, et al.
Chem Biol Interact. 2022 Jul 1;361:109978. doi: 10.1016/j.cbi.2022.109978. Epub 2022 May 11.
Chem Biol Interact. 2022.
PMID: 35561756
Item in Clipboard
Cite
Cite